Skip to main content
logo
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China flag China · Delayed Price · Currency is CNY
14.61
-0.16 (-1.08%)
Nov 6, 2026, 3:04 PM CST

SHE:000766 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
469.13272.1274.18177.45336.82301.59
Trading Asset Securities
0.081.071.091.050.130.18
Cash & Short-Term Investments
469.21273.18275.27178.49336.95301.77
Cash Growth
45.11%-0.76%54.22%-47.03%11.66%-40.60%
Accounts Receivable
501.55522.05526.27520.31470.42397.13
Other Receivables
28.4316.215.3334.8135.7661.52
Receivables
529.97538.26541.6555.12506.18458.65
Inventory
356.52365.2382.19369.17381.37384.58
Prepaid Expenses
-0.63----
Other Current Assets
19.8317.9210.918.4313.876.68
Total Current Assets
1,3761,1951,2101,1111,2381,152
Property, Plant & Equipment
970.14999.53989.841,0261,0531,087
Long-Term Investments
1,8541,8531,8481,9861,9891,989
Goodwill
1.91.91.91.91.91.91
Other Intangible Assets
383.96171.49184.96201.67216.61233.4
Long-Term Deferred Tax Assets
28.2627.6131.7313.614.6919.33
Long-Term Deferred Charges
1.85220.77190.22173.46160.89153.31
Other Long-Term Assets
9.427.0326.945.8510.475.37
Total Assets
4,6254,4774,4844,5194,6854,641

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
86.63123.02182.31191221.79150.59
Accrued Expenses
16.3837.7531.6334.8448.2338.79
Short-Term Debt
284.27216.75194.75130.1625.0440.06
Current Portion of Long-Term Debt
179.229.491,6058.26204.591,625
Current Portion of Leases
-0.180.174.60.290.26
Current Income Taxes Payable
12.980.197.542.555.520.79
Current Unearned Revenue
12.3910.7114.6611.6639.7911.5
Other Current Liabilities
95.27115.11121.26189.42126.6160.79
Total Current Liabilities
687.13513.192,157572.49671.862,028
Long-Term Debt
1,5611,586-1,5571,564183.75
Long-Term Leases
2.472.632.832.144.443.98
Long-Term Unearned Revenue
60.4162.5465.5364.7571.8378.9
Long-Term Deferred Tax Liabilities
1.211.912.994.364.947.3
Total Liabilities
2,3122,1662,2282,2012,3172,301

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
966.49966.49966.49966.49966.49966.49
Additional Paid-In Capital
-3,5793,5793,5793,6423,642
Retained Earnings
-2,135-2,137-2,172-2,228-2,272-2,302
Comprehensive Income & Other
3,481-97.86-118.7---
Total Common Equity
2,3132,3112,2552,3182,3372,307
Minority Interest
-0.18-0.080.010.4631.6432.6
Shareholders' Equity
2,3122,3102,2552,3182,3692,339
Total Liabilities & Equity
4,6254,4774,4844,5194,6854,641

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,0271,8151,8021,7031,7981,853
Net Cash (Debt)
-1,558-1,542-1,527-1,524-1,461-1,551
Net Cash Growth
------
Net Cash Per Share
-1.79-1.80-1.62-1.73-1.45-1.76
Filing Date Shares Outstanding
966.49966.49966.49966.49966.49966.49
Total Common Shares Outstanding
966.49966.49966.49966.49966.49966.49
Working Capital
688.4682-946.9538.72566.51-875.86
Book Value Per Share
2.392.392.332.402.422.39
Tangible Book Value
1,9272,1372,0692,1142,1182,071
Tangible Book Value Per Share
1.992.212.142.192.192.14
Buildings
-709.47688.35687.85685.07682.42
Machinery
-462.89445.26442.19425.08419.56
Construction In Progress
-268.86272.26267.94267.39259.15